GENOVESE, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 7.938
AS - Asia 6.703
EU - Europa 6.633
SA - Sud America 901
Continente sconosciuto - Info sul continente non disponibili 752
AF - Africa 171
OC - Oceania 83
Totale 23.181
Nazione #
US - Stati Uniti d'America 7.490
IT - Italia 1.822
CN - Cina 1.787
SG - Singapore 1.531
GB - Regno Unito 1.164
BD - Bangladesh 664
BR - Brasile 624
DE - Germania 533
HK - Hong Kong 499
ES - Italia 456
FR - Francia 455
RU - Federazione Russa 435
IN - India 378
VN - Vietnam 376
SE - Svezia 373
TR - Turchia 370
JP - Giappone 366
CA - Canada 291
IE - Irlanda 199
ID - Indonesia 185
NL - Olanda 183
DK - Danimarca 173
FI - Finlandia 159
KR - Corea 118
CH - Svizzera 108
BE - Belgio 101
AR - Argentina 79
MX - Messico 78
CO - Colombia 77
PL - Polonia 73
AT - Austria 71
AU - Australia 69
TW - Taiwan 55
TH - Thailandia 54
GR - Grecia 52
PH - Filippine 50
PT - Portogallo 47
CL - Cile 46
IR - Iran 45
RO - Romania 44
UA - Ucraina 39
SA - Arabia Saudita 37
CI - Costa d'Avorio 31
EG - Egitto 25
HU - Ungheria 25
ZA - Sudafrica 25
EC - Ecuador 23
IL - Israele 22
IQ - Iraq 21
MY - Malesia 21
AE - Emirati Arabi Uniti 19
CZ - Repubblica Ceca 18
MA - Marocco 18
SK - Slovacchia (Repubblica Slovacca) 16
PK - Pakistan 15
VE - Venezuela 15
KE - Kenya 14
PE - Perù 14
UZ - Uzbekistan 14
DZ - Algeria 13
HR - Croazia 13
SI - Slovenia 13
CR - Costa Rica 12
NZ - Nuova Zelanda 12
TN - Tunisia 12
JM - Giamaica 11
LT - Lituania 11
LU - Lussemburgo 9
GD - Grenada 8
LB - Libano 8
NO - Norvegia 8
PR - Porto Rico 8
PY - Paraguay 8
BH - Bahrain 7
GE - Georgia 7
JO - Giordania 7
UY - Uruguay 7
AZ - Azerbaigian 6
AP - ???statistics.table.value.countryCode.AP??? 5
BG - Bulgaria 5
BO - Bolivia 5
BY - Bielorussia 5
ET - Etiopia 5
LY - Libia 5
NP - Nepal 5
PS - Palestinian Territory 5
RS - Serbia 5
SC - Seychelles 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
CY - Cipro 4
DO - Repubblica Dominicana 4
EE - Estonia 4
GT - Guatemala 4
MD - Moldavia 4
MO - Macao, regione amministrativa speciale della Cina 4
NG - Nigeria 4
PA - Panama 4
CU - Cuba 3
EU - Europa 3
Totale 22.370
Città #
Singapore 902
Ashburn 755
Southend 667
Milan 496
Hong Kong 388
Chandler 370
San Jose 359
Council Bluffs 316
Fairfield 294
Santa Clara 262
New York 252
Beijing 243
Dallas 220
Ann Arbor 196
Los Angeles 193
Dublin 187
Princeton 165
Wilmington 163
Tokyo 155
Houston 151
Madrid 143
Redwood City 143
Seattle 139
Frankfurt am Main 130
Helsinki 128
Woodbridge 126
Jakarta 123
Istanbul 119
Guangzhou 110
Buffalo 103
Rome 103
São Paulo 100
Cambridge 94
Lauterbourg 93
Hanoi 89
London 89
Shanghai 87
Ho Chi Minh City 84
Bengaluru 82
Hefei 72
Des Moines 68
Nanjing 68
Barcelona 67
Central 66
Moscow 66
Chicago 63
Hangzhou 61
Toronto 61
Brussels 60
Ankara 59
Atlanta 57
Dearborn 56
Paris 56
Boardman 55
Montreal 52
Amsterdam 48
Mumbai 47
Phoenix 47
Rio de Janeiro 46
Hamburg 45
San Francisco 45
Seoul 44
Zurich 44
Dong Ket 42
Naples 42
Munich 41
Berlin 40
Brooklyn 40
Vienna 40
Florence 39
Jinan 39
Bologna 38
San Diego 38
Taipei 38
Tianjin 38
Chennai 36
Washington 36
Medellín 35
Valencia 34
Cangzhou 32
Abidjan 31
Duncan 31
Ottawa 31
Shenzhen 31
Turin 29
Changsha 28
Columbus 28
Izmir 28
Manchester 28
Miami 28
Nuremberg 28
Athens 27
Shenyang 27
Warsaw 27
Buenos Aires 26
Philadelphia 26
Campinas 25
Catania 25
Chengdu 25
Las Vegas 25
Totale 11.374
Nome #
Evidence for a “window of opportunity” in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicenter cohort study 3.096
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 1.164
Photobiomodulation as potential novel third line tool for non-invasive treatment of Hidradenitis Suppurativa 748
Lymphocytic variant of hypereosinophilic syndrome presenting with polymorphic cutaneous manifestations and nonspecific histopathological findings 580
Efficacy of a detergent combined with a moisturiser for the treatment of pruritus associated with xerosis in an elderly population affected by Kaposi's sarcoma 459
Clinical and immunopathological features of idiopathic cutaneous IgM/IgG vasculitis versus idiopathic skin-limited IgA vasculitis 439
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group 375
Late-onset post-mammoplasty pyoderma gangrenosum treated with tobacco-pouch suture combined with oral corticosteroids 371
SARS-CoV-2 Detection by Digital Polymerase Chain Reaction and Immunohistochemistry in Skin Biopsies from 52 Patients with Different COVID-19-Associated Cutaneous Phenotypes 354
Linear IgA bullous dermatosis in adults and children: A clinical and immunopathological study of 38 patients 332
Phthiriasis of the eyelashes 304
Skin Manifestations Associated with COVID-19 : Current Knowledge and Future Perspectives 303
Hidradenitis suppurativa and adalimumab in the COVID-19 era 295
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab : A Single-Center Real-Life Experience 291
Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders 289
Refractory disseminated superficial actinic porokeratosis effectively treated with cholesterol/lovastatin cream: a case report 273
Italian guidelines for the diagnosis and treatment of classic and iatrogenic Kaposi's sarcoma 264
Secondary syphilis masquerading as lupus vulgaris in an HIV-infected patient: A diagnosis suggested by histology 260
Post-surgical thyroid bed pyoderma gangrenosum mimicking recurrent papillary thyroid carcinoma 257
A Systematic Review of Treatment Options and Clinical Outcomes in Pemphigoid Gestationis 256
Dermatological Manifestations in Inflammatory Bowel Diseases 249
Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients 247
Hidradenitis suppurativa: the "bright side" of autoinflammation and hidden diseases 241
Coexistence of Kaposi's sarcoma and psoriasis : is there a hidden relationship? 239
Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic 236
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments 232
European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part I 219
Cutaneous metastasis from breast carcinoma clinically mimicking pyogenic granuloma 217
Mechanisms of Inflammation in Neutrophil-Mediated Skin Diseases 217
New insights into the pathogenesis of bullous pemphigoid : 2019 update 217
Cutaneous manifestations in patients with COVID-19 : a preliminary review of an emerging issue 214
European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part II 204
Clinical and serological predictors of relapse in pemphigus: a study of 143 patients 198
Aberrant breast tissue in complete androgen insensitivity syndrome 192
Keratosis lichenoides chronica: A case report and focused overview of the literature 189
SYNDROMIC HIDRADENITIS SUPPURATIVA: GENOTYPE-PHENOTYPE CORRELATION THROUGH WHOLE-EXOME SEQUENCING IN 10 UNRELATED PATIENTS 188
Autoimmune bullous diseases in non-HIV Kaposi's sarcoma : a retrospective study in a large cohort of patients 188
SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris 185
Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement 185
A dermatologic perspective on autoinflammatory diseases 184
Urticarial eruption in a patient with intermittent fever and monoclonal IgM gammopathy 183
Autoimmune bullous diseases during pregnancy : insight into pathogenetic mechanisms and clinical features 179
PD-L1 expression in tumour microenvironment supports the rationale for immune checkpoint blockade in classic Kaposi's sarcoma 176
Lichen planopilaris and dermatitis herpetiformis: a fortuitous association? 176
An integrated approach to unravel hidradenitis suppurativa etiopathogenesis 175
Primary syphilis of the neck mimicking a pyodermatitis 174
Ultrasonographic findings in primary umbilical endometriosis 170
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis 167
Lichen planus hypertrophicus-inversus occurring in a patient with Bannayan-Riley-Ruvalcaba syndrome 165
Clinical, genetic, and ultrasonographic features of periumbilical perforating pseudoxanthoma elasticum 164
Five cases of new-onset pemphigus following vaccinations against coronavirus disease 2019 163
Eosinophilic Dermatoses: Recognition and Management 163
Necrobiotic xanthogranuloma in IgG-κ multiple myeloma 161
Iatrogenic Kaposi's Sarcoma : a Retrospective Cohort Study in an Italian Tertiary Care Centre 160
Comment on: Treatment of psoriasis with ustekinumab in a patient with HIV-related Kaposi sarcoma 157
Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273 155
Oesophagitis dissecans superficialis as the presenting sign oisolated oesophageal mucous membrane pemphigoid 155
Chronic spontaneous urticaria in clinical practice: a pilot survey about attitudes and perceptions on assessment, diagnostic work-up and dietary management 151
The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicentre study of 200 adult patients 151
An ulcer on the lower lip 150
Varicella-like exanthem associated with COVID-19 in an 8-year-old girl : a diagnostic clue? 149
Bullous pemphigoid associated with COVID-19 vaccines : An Italian multicentre study 144
Pustular psoriasis : from pathophysiology to treatment 142
Acetaminophen-induced generalized fixed drug eruption in a 5-year-old girl 141
Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis : two cases and literature review 140
Clinical and laboratory features of 244 men with primary syphilis: a 5-year single-centre retrospective study 140
A sweet fever 136
Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings 135
Brunsting-Perry pemphigoid: a systematic review 132
Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis 131
Multiple nodules on the scrotal wall 128
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 125
Therapeutic management of chronic spontaneous urticaria in clinical practice: results from a pilot survey 125
Dermal Amyloid Deposits: A Possible Misleading Pathologic Finding 123
Ultrasonographic intraoperative monitoring and follow-up of Kaposi's sarcoma nodules under treatment with intralesional vincristine 123
25-Hydroxyvitamin D serum levels inversely correlate to disease severity and serum C-reactive protein levels in patients with hidradenitis suppurativa 120
Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate 119
Rosacea-like cutaneous localization of small lymphocytic lymphoma unmasked by high-frequency-ultrasound 118
The Intriguing Links between Psoriasis and Bullous Pemphigoid 116
Clinical and histopathologic study of 39 patients with imported tungiasis 114
Treatment of Autoimmune Bullous Diseases During Pregnancy and Lactation : A Review Focusing on Pemphigus and Pemphigoid Gestationis 113
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience 112
Tinea corporis caused by Trichophyton equinum in a rider and review of the literature 109
Case of a severe vulgaris and foliaceus pemphigus in a young patient treated with rituximab, with subsequent development of chronic urticaria 109
Imatinib-induced pyoderma gangrenosum in a patient with chronic myeloid leukemia 108
Venous Thromboembolism in Chronic Inflammatory Skin Diseases-The Need to Consider Bullous Pemphigoid 108
Baseline D-dimer plasma levels correlate with disease activity but not with the response to omalizumab in chronic spontaneous urticaria 107
Eruptive pyogenic granulomas following coronavirus disease 2019 104
Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action 103
Response to "Reply to 'Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients': To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out" 97
Follicular larva migrans 96
Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole exome sequencing approach 95
Bullous erythroderma: novel association of pityriasis rubra pilaris with bullous pemphigoid 93
Reply to “New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin” 91
Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses : an intraindividual comparative analysis 89
Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria 89
Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study 86
PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa 84
Miescher nevus as devil's mark, but also as beauty mark 80
Idiopathic chilblains in myelomonocytic leukemia : not a simple association 79
Totale 22.799
Categoria #
all - tutte 62.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.157 0 0 233 190 190 216 187 222 236 184 169 330
2022/20232.461 256 198 165 215 238 324 147 193 216 134 249 126
2023/20242.291 163 180 184 186 315 191 166 146 122 159 217 262
2024/20253.626 197 385 174 308 318 215 133 348 250 280 346 672
2025/20267.133 607 422 616 612 604 404 703 379 819 495 860 612
2026/20271.601 613 781 207 0 0 0 0 0 0 0 0 0
Totale 23.181